Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biosimilars are alternatives to existing patented and approved biologics that have similar medicinal properties compared to the original biologics. Biosimilars are slightly different in structure from the original biosimilars but must have similar safety and efficacy profiles compared to the original biosimilars.
The market for biosimilars is characterized by a large number of pharmaceutical giants and emerging enterprises all over the world. Europe region is expected to lead the global market owing to the presence of many major players in the region. The global Biosimilars market is expected to reach USD 44.56 Billion by year 2026, at a CAGR of 28.7%.
The global biosimilars market is driven by factors such as the global prevalence of target disease prevalence across the globe, the launch of biosimilars by various market players, and favorable investments scenario. However, risks to drug efficacy and stringent government regulations are expected to adversely affect market growth.
This report elaborates on the current development of the Biosimilars industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Sandoz International
Merck KGaA
Mylan
Amgen
Biocon
Roche Diagnostics
Hospira
Teva Pharmaceutical
By Type:
Others
Tablets
Injection
By Application:
Rheumatoid Arthrtis
Ankylosing Spondylitis
Cardiovascular
Tumor
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Biosimilars Market Overview 2018-2029
-
1.1 China Biosimilars Industry Development Overview
-
1.2 China Biosimilars Industry Development History
-
1.3 China Biosimilars Industry Market Size (2018-2029)
-
1.4 China Biosimilars Market Analysis by Type from Production Side
-
1.4.1 China Biosimilars Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.2 China Biosimilars Production Volume, Production Value and Growth Rate of Tablets (2018-2029)
-
1.4.3 China Biosimilars Production Volume, Production Value and Growth Rate of Injection (2018-2029)
-
1.5 China Biosimilars Market Analysis by Application from Consumption End
-
1.5.1 China Biosimilars Sales Volume, Sales Value and Growth Rate of Rheumatoid Arthrtis (2018-2029)
-
1.5.2 China Biosimilars Sales Volume, Sales Value and Growth Rate of Ankylosing Spondylitis (2018-2029)
-
1.5.3 China Biosimilars Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)
-
1.5.4 China Biosimilars Sales Volume, Sales Value and Growth Rate of Tumor (2018-2029)
-
1.6 China Biosimilars Market Analysis by Region
-
1.6.1 North China Biosimilars Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Biosimilars Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Biosimilars Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Biosimilars Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Biosimilars Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Biosimilars Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Biosimilars Market Size and Growth Rate from 2018-2029
Chapter 2 China Biosimilars Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Biosimilars Market Status and Competition at home and abroad in 2023
-
2.2.2 China Biosimilars Market Status and Competition Analysis in 2023
-
2.2.3 China Biosimilars Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Biosimilars Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Biosimilars Industry Development
Chapter 3 BiosimilarsIndustry Chain Analysis
-
3.1 Biosimilars Industry Chain
-
3.2 Biosimilars Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Biosimilars Market
-
3.3 Biosimilars Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Biosimilars Market
Chapter 4 China Biosimilars Market, by Type
-
4.1 China Biosimilars Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Biosimilars Total Production Volume and Growth Rate from Production Side
-
4.5 China Biosimilars Production Volume and Growth Rate, by Type
-
4.5.1 China Biosimilars Production Volume and Growth Rate of Others
-
4.5.2 China Biosimilars Production Volume and Growth Rate of Tablets
-
4.5.3 China Biosimilars Production Volume and Growth Rate of Injection
Chapter 5 China Biosimilars Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Biosimilars Total Market Size and Growth Rate from Consumption End
-
5.5 China Biosimilars Market Size and Growth Rate, by Application
-
5.5.1 China Biosimilars Market Size and Growth Rate of Rheumatoid Arthrtis
-
5.5.2 China Biosimilars Market Size and Growth Rate of Ankylosing Spondylitis
-
5.5.3 China Biosimilars Market Size and Growth Rate of Cardiovascular
-
5.5.4 China Biosimilars Market Size and Growth Rate of Tumor
Chapter 6 China Biosimilars Market, by Region
-
6.1 China Biosimilars Production Volume and Production Value, by Region
-
6.2 China Biosimilars Sales Volume and Sales Value, by Region
Chapter 7 North China Biosimilars Market Analysis
-
7.1 North China Biosimilars Market, by Type
-
7.2 North China Biosimilars Market, by Application
Chapter 8 Central China Biosimilars Market Analysis
-
8.1 Central China Biosimilars Market, by Type
-
8.2 Central China Biosimilars Market, by Application
Chapter 9 South China Biosimilars Market Analysis
-
9.1 South China Biosimilars Market, by Type
-
9.2 South China Biosimilars Market, by Application
Chapter 10 East China Biosimilars Market Analysis
-
10.1 East China Biosimilars Market, by Type
-
10.2 East China Biosimilars Market, by Application
Chapter 11 Northeast China Biosimilars Market Analysis
-
11.1 Northeast China Biosimilars Market, by Type
-
11.2 Northeast China Biosimilars Market, by Application
Chapter 12 Southwest China Biosimilars Market Analysis
-
12.1 Southwest China Biosimilars Market, by Type
-
12.2 Southwest China Biosimilars Market, by Application
Chapter 13 Northwest China Biosimilars Market Analysis
-
13.1 Northwest China Biosimilars Market, by Type
-
13.2 Northwest China Biosimilars Market, by Application
Chapter 14 Company Profiles
-
14.1 Sandoz International
-
14.1.1 Sandoz International Company Profile
-
14.1.2 Sandoz International Biosimilars Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Merck KGaA
-
14.2.1 Merck KGaA Company Profile
-
14.2.2 Merck KGaA Biosimilars Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Mylan
-
14.3.1 Mylan Company Profile
-
14.3.2 Mylan Biosimilars Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Amgen
-
14.4.1 Amgen Company Profile
-
14.4.2 Amgen Biosimilars Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Biocon
-
14.5.1 Biocon Company Profile
-
14.5.2 Biocon Biosimilars Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Roche Diagnostics
-
14.6.1 Roche Diagnostics Company Profile
-
14.6.2 Roche Diagnostics Biosimilars Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Hospira
-
14.7.1 Hospira Company Profile
-
14.7.2 Hospira Biosimilars Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Teva Pharmaceutical
-
14.8.1 Teva Pharmaceutical Company Profile
-
14.8.2 Teva Pharmaceutical Biosimilars Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Biosimilars Industry Research Conclusions
-
15.2 Biosimilars Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Biosimilars Industry Market Size (2018-2029)
-
Figure China Biosimilars Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Biosimilars Production Volume, Production Value and Growth Rate of Tablets (2018-2029)
-
Figure China Biosimilars Production Volume, Production Value and Growth Rate of Injection (2018-2029)
-
Figure China Biosimilars Sales Volume, Sales Value and Growth Rate of Rheumatoid Arthrtis (2018-2029)
-
Figure China Biosimilars Sales Volume, Sales Value and Growth Rate of Ankylosing Spondylitis (2018-2029)
-
Figure China Biosimilars Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)
-
Figure China Biosimilars Sales Volume, Sales Value and Growth Rate of Tumor (2018-2029)
-
Figure North China Biosimilars Market Size and Growth Rate from 2018-2029
-
Figure Central China Biosimilars Market Size and Growth Rate from 2018-2029
-
Figure South China Biosimilars Market Size and Growth Rate from 2018-2029
-
Figure East China Biosimilars Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Biosimilars Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Biosimilars Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Biosimilars Market Size and Growth Rate from 2018-2029
-
Figure Biosimilars Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Biosimilars Market Share by Type in 2018
-
Figure China Biosimilars Market Share by Type in 2023
-
Figure China Biosimilars Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Biosimilars Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Biosimilars Production Volume and Growth Rate of Tablets (2018-2023)
-
Figure China Biosimilars Production Volume and Growth Rate of Injection (2018-2023)
-
Figure China Biosimilars Market Share by Application in 2018
-
Figure China Biosimilars Market Share by Application in 2023
-
Figure China Biosimilars Total Market Size and Growth Rate from Consumption End
-
Figure China Biosimilars Market Size and Growth Rate of Rheumatoid Arthrtis (2018-2023)
-
Figure China Biosimilars Market Size and Growth Rate of Ankylosing Spondylitis (2018-2023)
-
Figure China Biosimilars Market Size and Growth Rate of Cardiovascular (2018-2023)
-
Figure China Biosimilars Market Size and Growth Rate of Tumor (2018-2023)
-
Table China Biosimilars Production Volume by Region (2018-2023)
-
Table China Biosimilars Production Volume Share by Region (2018-2023)
-
Figure China Biosimilars Production Volume Share by Region (2018-2023)
-
Table China Biosimilars Production Value by Region (2018-2023)
-
Table China Biosimilars Production Value Share by Region (2018-2023)
-
Figure China Biosimilars Production Value Share by Region (2018-2023)
-
Table China Biosimilars Sales Volume by Region (2018-2023)
-
Table China Biosimilars Sales Volume Share by Region (2018-2023)
-
Figure China Biosimilars Sales Volume Share by Region (2018-2023)
-
Table China Biosimilars Sales Value by Region (2018-2023)
-
Table China Biosimilars Sales Value Share by Region (2018-2023)
-
Figure China Biosimilars Sales Value Share by Region (2018-2023)
-
Table North China Biosimilars Production Volume by Type (2018-2023)
-
Table North China Biosimilars Production Volume Share by Type (2018-2023)
-
Figure North China Biosimilars Production Volume Share by Type (2018-2023)
-
Table North China Biosimilars Sales Volume by Application (2018-2023)
-
Table North China Biosimilars Sales Volume Share by Application (2018-2023)
-
Figure North China Biosimilars Sales Volume Share by Application (2018-2023)
-
Table Central China Biosimilars Production Volume by Type (2018-2023)
-
Table Central China Biosimilars Production Volume Share by Type (2018-2023)
-
Figure Central China Biosimilars Production Volume Share by Type (2018-2023)
-
Table Central China Biosimilars Sales Volume by Application (2018-2023)
-
Table Central China Biosimilars Sales Volume Share by Application (2018-2023)
-
Figure Central China Biosimilars Sales Volume Share by Application (2018-2023)
-
Table South China Biosimilars Production Volume by Type (2018-2023)
-
Table South China Biosimilars Production Volume Share by Type (2018-2023)
-
Figure South China Biosimilars Production Volume Share by Type (2018-2023)
-
Table South China Biosimilars Sales Volume by Application (2018-2023)
-
Table South China Biosimilars Sales Volume Share by Application (2018-2023)
-
Figure South China Biosimilars Sales Volume Share by Application (2018-2023)
-
Table East China Biosimilars Production Volume by Type (2018-2023)
-
Table East China Biosimilars Production Volume Share by Type (2018-2023)
-
Figure East China Biosimilars Production Volume Share by Type (2018-2023)
-
Table East China Biosimilars Sales Volume by Application (2018-2023)
-
Table East China Biosimilars Sales Volume Share by Application (2018-2023)
-
Figure East China Biosimilars Sales Volume Share by Application (2018-2023)
-
Table Northeast China Biosimilars Production Volume by Type (2018-2023)
-
Table Northeast China Biosimilars Production Volume Share by Type (2018-2023)
-
Figure Northeast China Biosimilars Production Volume Share by Type (2018-2023)
-
Table Northeast China Biosimilars Sales Volume by Application (2018-2023)
-
Table Northeast China Biosimilars Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Biosimilars Sales Volume Share by Application (2018-2023)
-
Table Southwest China Biosimilars Production Volume by Type (2018-2023)
-
Table Southwest China Biosimilars Production Volume Share by Type (2018-2023)
-
Figure Southwest China Biosimilars Production Volume Share by Type (2018-2023)
-
Table Southwest China Biosimilars Sales Volume by Application (2018-2023)
-
Table Southwest China Biosimilars Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Biosimilars Sales Volume Share by Application (2018-2023)
-
Table Northwest China Biosimilars Production Volume by Type (2018-2023)
-
Table Northwest China Biosimilars Production Volume Share by Type (2018-2023)
-
Figure Northwest China Biosimilars Production Volume Share by Type (2018-2023)
-
Table Northwest China Biosimilars Sales Volume by Application (2018-2023)
-
Table Northwest China Biosimilars Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Biosimilars Sales Volume Share by Application (2018-2023)
-
Table Sandoz International Company Profile
-
Table Sandoz International Biosimilars Revenue, Price and Gross (2018-2023)
-
Table Merck KGaA Company Profile
-
Table Merck KGaA Biosimilars Revenue, Price and Gross (2018-2023)
-
Table Mylan Company Profile
-
Table Mylan Biosimilars Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Biosimilars Revenue, Price and Gross (2018-2023)
-
Table Biocon Company Profile
-
Table Biocon Biosimilars Revenue, Price and Gross (2018-2023)
-
Table Roche Diagnostics Company Profile
-
Table Roche Diagnostics Biosimilars Revenue, Price and Gross (2018-2023)
-
Table Hospira Company Profile
-
Table Hospira Biosimilars Revenue, Price and Gross (2018-2023)
-
Table Teva Pharmaceutical Company Profile
-
Table Teva Pharmaceutical Biosimilars Revenue, Price and Gross (2018-2023)
-
